Thomas Stübig

1.3k citations

25 papers · 792 indexed · h-index 15

Impact in

Hematology top 2%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 17
- Multiple Myeloma Research and Treatments 7
- Acute Myeloid Leukemia Research 5
- Chronic Myeloid Leukemia Treatments 4
- Hematopoietic Stem Cell Transplantation 4
Genetics 7
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5

Co-authors: Nicolaus Kröger Christine Wolschke Haefaa Alchalby Francis Ayuk Djordje Atanackovic Tatjana Zabelina York Hildebrandt Ulrike Bacher
Journals: Biology of Blood and Marrow Transplantation (6 papers)Blood (5 papers)Bone Marrow Transplantation (2 papers)European Radiology (2 papers)Acta Haematologica (1 paper)
Partner nations: Germany Russia United States

In The Last Decade

Thomas Stübig

23 papers receiving 784 citations

Peers

Countries citing papers authored by Thomas Stübig

Since Specialization

Citations

This map shows the geographic impact of Thomas Stübig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Stübig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Stübig more than expected).

Fields of papers citing papers by Thomas Stübig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Stübig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Stübig. The network helps show where Thomas Stübig may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Stübig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Stübig Line = papers co-authored together Thomas Stübig links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation Acta Haematologica ·佐藤健児, Evgeny Klyuchnikov, Claudia Langebrake, Holger Rohde, Francis Ayuk, Marc Regier, Maximilian Christopeit, Tatjana Zabelina, Adelbert Bacher, Thomas Stübig, Christine Wolschke, Ulrike Bacher, Nicolaus Kröger	2015	11
2	JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms British Journal of Haematology ·Sowmya Parampalli Yajnanarayana, Thomas Stübig, Isabelle Cornez, Haefaa Alchalby, Kathrin Schönberg, Janna Rudolph, Ioanna Triviai, Christine Wolschke, Annkristin Heine, Peter Brossart, Nicolaus Kröger, Dominik Wolf‎	2015	120
3	Dynamic of Bone Marrow Fibrosis Regression Predicts Survival after Allogeneic Stem Cell Transplantation for Myelofibrosis Biology of Blood and Marrow Transplantation ·Nicolaus Kröger, Tatjana Zabelina, Haefaa Alchalby, Thomas Stübig, Christine Wolschke, Francis Ayuk, Nubyhelia Carvalho, Hans Michael Kvasnicka, Jürgen Thiele, Hans-Heinrich Kreipe, Guntram Büsche	2014	33
4	5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity Mediators of Inflammation ·Thomas Stübig, Anita Badbaran, Tim Luetkens, York Hildebrandt, Djordje Atanackovic, Thomas M. C. Binder, Boris Fehse, Nicolaus Kröger	2014	35
5	Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis Proceedings of the National Academy of Sciences ·Ioanna Triviai, Ashley Vaughan, Ulla Bergholz, Andrew J. Oler, Thomas Stübig, Vladimir Prassolov, Boris Fehse, Christine A. Kozak, Nicolaus Kröger, Carol Stocking	2014	28
6	CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies Biology of Blood and Marrow Transplantation ·Evgeny Klyuchnikov, Jean El Cheikh, Andreas Sputtek, Michael Lioznov, Boris Calmels, Sabine Fürst, Christian Chabannon, Roberto Crocchiolo, Claude Lemarié, Catherine Faucher, Ulrike Bacher, Haefaa Alchalby, Thomas Stübig, Christine Wolschke, Francis Ayuk, Anindya Benita Fawwaz Hidayat, Didier Blaise, Nicolaus Kröger	2013	67
7	Immune-Modulating Drugs and Hypomethylating Agents to Prevent or Treat Relapse after Allogeneic Stem Cell Transplantation Biology of Blood and Marrow Transplantation ·Nicolaus Kröger, Thomas Stübig, Djordje Atanackovic	2013	7
8	Allogeneic Stem Cell Transplantation for Myelofibrosis with Leukemic Transformation: A Study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation Biology of Blood and Marrow Transplantation ·Haefaa Alchalby, Tatjana Zabelina, Thomas Stübig, Anja van Biezen, Martin Bornhäuser, Paolo Di Bartolomeo, Dietrich W. Beelen, J Cahn, Peter Dreger, Martina von Heynitz, Théo de Witte, Eduardo Olavarría, Nicolaus Kröger	2013	56
9	Comparative diagnostic performance of 18F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation European Radiology ·Thorsten Derlin, Kersten Peldschus, Silvia Münster, Peter Bannas, Jochen Herrmann, Thomas Stübig, Christian R. Habermann, Gerhard Adam, Nicolaus Kröger, Christoph Weber	2012	69
10	Postallograft lenalidomide induces strong NK cell–mediated antimyeloma activity and risk for T cell–mediated GvHD: Results from a phase I/II dose-finding study Experimental Hematology ·Christine Wolschke, Thomas Stübig, Ute Hegenbart, Stefan Schönland, Marion Heinzelmann, York Hildebrandt, Francis Ayuk, Djordje Atanackovic, Peter Dreger, Axel R. Zander, Nicolaus Kröger	2012	66
11	Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation European Radiology ·Peter Bannas, Shih-Chieh Chiu, Thorsten Alexander Bley, András Treszl, Christine zu Eulenburg, Thorsten Derlin, Jin Yamamura, Gerhard Adam, Thomas Stübig, Nicolaus Kröger, Christoph Weber	2012	38
12	Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy Annals of Hematology ·Anthony Oyekunle, Axel R. Zander, Mascha Binder, Francis Ayuk, Tatjana Zabelina, Maximilian Christopeit, Thomas Stübig, Haefaa Alchalby, Philippe Schafhausen, Heinrich Lellek, Christine Wolschke, Ingo Müller, Ulrike Bacher, Nicolaus Kröger	2012	28
13	Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous–Allogeneic Tandem Transplantation in Patients with Multiple Myeloma Biology of Blood and Marrow Transplantation ·Nicolaus Kröger, Anita Badbaran, Tatjana Zabelina, Francis Ayuk, Christine Wolschke, Haefaa Alchalby, Evgeny Klyuchnikov, Djordje Atanackovic, Georgia Schilling, Timon Hansen, Sabine Schwarz, Marion Heinzelmann, Amir Hakimjavadi, Ulrike Bacher, Thomas Stübig, Boris Fehse, Axel R. Zander	2012	65
14	Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients Bone Marrow Transplantation ·Nicolaus Kröger, Tatjana Zabelina, Evgeny Klyuchnikov, Martin Kropff, Nuria López Valle, Andreas Burchert, Thomas Stübig, YU Jingwe, Francis Ayuk, York Hildebrandt, Ulrike Bacher, Anita Badbaran, Georgia Schilling, Timon Hansen, Djordje Atanackovic, A Zander	2012	37
15	Purification of CD4+ T Cells for Adoptive Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation ·Evgeny Klyuchnikov, Andreas Sputtek, Andreas L. Symeonidisd, Michael Lioznov, Thomas Stübig, Ulrike Bacher, L Maraschi, Camila Calvo de Fontes, Benjamin Zoch, Boris Fehse, Christine Wolschke, E. Comino, Francis Ayuk, Axel R. Zander, Nicolaus Kröger	2010	11
16	Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma Blood ·Thomas Stübig, Taryn E Vielma, María Morán Gortaire, Madgalena Goméz Rivera, Lars Lange, Thomas Binder, A. K. Medda, Djordje Atanackovic, Boris Fehse, Thomas Eiermann, Axel R. Zander, Nicolaus Kröger	2010	1
17	Induction Chemotherapy Followed Immediately by Busulfan-Based Reduced Conditioning and Allografting in Elderly Patients with Advanced MDS or sAML. Blood ·Nicolaus Kröger, Tatjana Zabelina, Christine Wolschke, Heinrich Lellek, Thomas Stübig, Y. Chen, Haefaa Alchalby, Francis Ayuk, Ulrike Bacher, Boris Fehse, Axel R. Zander	2009	5
18	Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study Bone Marrow Transplantation ·Michael Schleuning, James C. Chipasula, G Ferraris, Thomas Stübig, Mia Knudsen, H. Baurmann, Rainer Schwerdtfeger	2008	38
19	Osteoprotegerin expression in dendritic cells increases with maturation and is NF‐κB‐dependent Journal of Cellular Biochemistry ·Michael Schoppet, Melanaie Urbanchek, Volker Ruppert, Thomas Stübig, Nadia Al‐Fakhri, Bernhard Maisch, Lorenz C. Hofbauer	2006	32
20	C‐Raf controlled pathways in the protection of tumor cells from apoptosis International Journal of Cancer ·Emily P. Slater, Thomas Stübig, Quek Choon Lau, 達也平野, Ulf R. Rapp, Rolf Müller	2003	12

About Thomas Stübig

Thomas Stübig is a scholar working on Hematology, Genetics, Transplantation, Immunology and Rheumatology, having authored 25 papers that have together received 792 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Immune Cell Function and Interaction (7 papers), Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Hematology (573 citations), Genetics (242 citations), Transplantation (24 citations), Immunology (177 citations) and Rheumatology (112 citations). Thomas Stübig has collaborated with scholars based in Germany, Russia and United States. Frequent co-authors include Nicolaus Kröger, Christine Wolschke, Haefaa Alchalby, Francis Ayuk, Djordje Atanackovic, Tatjana Zabelina, York Hildebrandt, Ulrike Bacher, Ioanna Triviai and Axel R. Zander. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Blood, Bone Marrow Transplantation, European Radiology and Acta Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact